ArticleProceedings of the National Academy of Sciences of the United States of America2004

A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction.

Stefano Fiorucci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.